CXL146, a Novel 4h-Chromene Derivative, Targets GRP78 to Selectively Eliminate Multidrug Resistant Cancer Cells

Molecular Pharmacology - United States
doi 10.1124/mol.119.118745
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Society for Pharmacology & Experimental Therapeutics (ASPET)

Related search

Crystal Structure of the Calcium ATPase SERCA in Complex to a Novel Anti-Cancer Agent That Targets Multidrug-Resistant Leukemia

Biophysical Journal
Biophysics
2016English

Bezielle Selectively Targets Mitochondria of Cancer Cells to Inhibit Glycolysis and OXPHOS

PLoS ONE
Multidisciplinary
2012English

Nanomicellar Paclitaxel Increases Cytotoxicity of Multidrug Resistant Breast Cancer Cells

Cancer Letters
Cancer ResearchOncology
2009English

A Novel Synthetic Dihydroindeno[1,2-B] Indole Derivative (LS-2-3j) Reverses ABCB1- And ABCG2-Mediated Multidrug Resistance in Cancer Cells

Molecules
Organic ChemistryMolecular MedicineAnalytical ChemistryTheoretical ChemistryPharmaceutical ScienceMedicineDrug DiscoveryChemistryPhysical
2018English

6,8-Diiodo-4-Oxo-4h-Chromene-3-Carbaldehyde

Acta Crystallographica Section E Structure Reports Online
2014English

Silver Nanoweapons: A Novel Tool Against Multidrug Resistant Bacteria

Biosciences Biotechnology Research Asia
BiotechnologyAgronomyCrop ScienceDrug Discovery
2016English

Isolation and Characterization of Hepatitis C Virus Resistant to a Novel Phenanthridinone Derivative

Antiviral Chemistry and Chemotherapy
MedicineVirologyDrug DiscoveryPharmacology
2015English

Novel HER2 Aptamer Selectively Delivers Cytotoxic Drug to HER2-positive Breast Cancer Cells in Vitro

Journal of Translational Medicine
BiochemistryMedicineGeneticsMolecular Biology
2012English

Phosphosulindac (OXT-328) Selectively Targets Breast Cancer Stem Cells in Vitro and in Human Breast Cancer Xenografts

Stem Cells
MedicineMolecular MedicineDevelopmental BiologyCell Biology
2012English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy